Optimal Treatment of cT2N0 Esophageal Carcinoma: Is Upfront Surgery Really the Way?
Giovanni CapovillaLucia MolettaElisa Sefora PierobonRenato SalvadorLuca ProvenzanoGianpietro ZanchettinMario CostantiniStefano MeriglianoMichele ValmasoniPublished in: Annals of surgical oncology (2021)
Given the high rate of understaged patients in this study (63.4%), the authors advocate for combining the induction therapy with surgery in cT2N0, achieving better survival with similar morbidity and mortality.
Keyphrases
- minimally invasive
- end stage renal disease
- coronary artery bypass
- computed tomography
- image quality
- chronic kidney disease
- ejection fraction
- dual energy
- contrast enhanced
- peritoneal dialysis
- prognostic factors
- surgical site infection
- magnetic resonance imaging
- magnetic resonance
- coronary artery disease
- mesenchymal stem cells
- atrial fibrillation
- cell therapy
- bone marrow
- free survival